← Back to bills and search results
2025 · Regular session · House bill
HB3441
HB3441 adds a Texas civil claim against a vaccine manufacturer when it advertises a vaccine in Texas and the advertised vaccine causes harm or injury to an individual.
Official caption: Relating to the liability of vaccine manufacturers that advertise a harmful vaccine.
Official report lists House author(s): Luther, Leach, LaHood, Longoria, Schofield. This does not identify sponsors or amendment drafters.
Bill explanation published · Version and amendment review scope is stated below · Individual amendment records may not be separately annotated.
Bill highlights
Selected points from the published explanation. Follow each point to its source-linked context; conditions and limits may matter.
- HB3441 adds a Texas civil claim against a vaccine manufacturer when it advertises a vaccine in Texas and the advertised vaccine causes harm or injury to an individual.
- Advertising means a communication the manufacturer purchases to promote its vaccine, including television, radio, print, Internet and electronic media, product placement, paid influencers and other paid promotion.
- The law does not ban all vaccine advertising or declare all vaccines harmful.
- Federal limits still matter: Texas legislation does not erase federal vaccine-law protections.
What does it do?
HB3441 adds a Texas civil claim against a vaccine manufacturer when it advertises a vaccine in Texas and the advertised vaccine causes harm or injury to an individual. A winning claimant must receive actual damages, court costs and reasonable attorney’s fees. The statute gives an individual three years after the claim accrues to bring the action. It does not define that starting point as simply the day an advertisement appeared. Final law
Advertising means a communication the manufacturer purchases to promote its vaccine, including television, radio, print, Internet and electronic media, product placement, paid influencers and other paid promotion. The definition excludes provider–patient discussions, written vaccine materials a provider gives a patient, and vaccine posters, decorations, materials or promotional items displayed or made available in clinical settings.
The law does not ban all vaccine advertising or declare all vaccines harmful. Its text requires injury caused by the advertised vaccine; it does not expressly require that the claimant saw or relied on the advertisement, or that the advertisement was false. Signed June 20, 2025, it took effect September 1, 2025, and applies only to claims accruing on or after that date. Official history
Federal limits still matter. Texas legislation does not erase federal vaccine-law protections. For qualifying vaccine injuries, federal law generally requires using the federal compensation process before pursuing specified damages lawsuits. Federal law also limits manufacturer liability, and the Supreme Court’s *Bruesewitz* decision holds that the National Childhood Vaccine Injury Act bars state-law design-defect claims seeking compensation for vaccine side effects. Separately, the PREP Act provides immunity for covered countermeasures under qualifying federal declarations, subject to its conditions and narrow exception. Whether a particular HB3441 claim survives those rules depends on the vaccine, claim and applicable federal protection—not merely whether an advertisement ran. Federal compensation prerequisite · Federal liability standards · Supreme Court decision · PREP Act
What changed along the way?
The introduced bill already proposed liability for an advertised vaccine causing injury and recovery of actual damages, costs and attorney’s fees. The House committee substitute added the detailed paid-advertising definition and clinical-setting exclusions, expressly tied injury to the advertised vaccine, and added the three-year filing provision. Those changes remained in the engrossed, Senate committee and final versions.
The official amendment index lists no separate amendments. That does not mean the bill was unchanged: the committee substitute was the significant revision. The Senate reported the bill without amendments, and the final text retained the House substitute’s operative provisions. Introduced text · House substitute · All text versions · Amendment index
For the full amendment record, open the official amendment index.
Official bill versions
Compare the published text versions in the official text index. A change is not attributed to a specific amendment here without a verified record.
Who could benefit—and who could bear the costs?
People who can establish a qualifying injury and overcome applicable legal defenses gain a state-law route to actual damages and reimbursement of litigation costs. Manufacturers that buy covered advertising face potential defense expenses and awards, and may reassess advertising. The clinical-material exclusions preserve ordinary patient information outside this advertising definition. Changes in advertising, vaccine availability or prices are possible responses, not outcomes established by this review.
All three official fiscal notes—introduced, House substitute and engrossed—anticipated no significant fiscal impact on state or local government, with public costs absorbed using existing resources. They do not estimate private lawsuit costs or guarantee a claimant’s recovery. Final available fiscal note
Review boundary: This is a source-checked explanation of the enacted Texas claim, not a medical finding about any vaccine or a prediction that a particular lawsuit will succeed. The federal comparison uses official statutes and the controlling design-defect decision; it is not a certification of every current federal declaration, claim deadline or later court proceeding involving this Texas law.
Official sources
- Bill history and latest recorded action
- Bill versions, analyses and fiscal notes
- Action history and votes
- Amendment index
Catalog report retrieved 2026-10-25. Check the official record for corrections or later changes.
